NEW YORK ( TheStreet) -- Accuray (Nasdaq: ARAY) hit a new 52-week low Thursday as it is currently trading at $3.86, below its previous 52-week low of $3.88 with 27,174 shares traded as of 9:30 a.m. ET. Average volume has been 875,900 shares over the past 30 days.

Accuray has a market cap of $247.8 million and is part of the health care sector and health services industry. Shares are down 41.6% year to date as of the close of trading on Wednesday.

Accuray Incorporated designs, develops, and sells the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors.
  • Practice your ARAY trading strategies and win cash in our stock game.

TheStreet Ratings rates Accuray as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. You can view the full Accuray Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.